Phototherapy Market to grow at a CAGR of 5.12% during 2025 to 2035; Driven by Rising Prevalence of Skin Disorders and Increasing Adoption of Phototherapy Treatments

Market Overview

The Global Phototherapy Market Size was estimated at 0.62 USD Billion in 2024. The phototherapy industry is projected to grow from USD 0.6517 Billion in 2025 to USD 1.074 Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 5.12% during the forecast period 2025 - 2035.

Segmental Analysis

Global Phototherapy Market has been segmented based on Product, Radiation, Application, and End User.

Based on product, the global phototherapy market has been segmented into conventional phototherapy equipment, LED phototherapy equipment, fiberoptic phototherapy equipment, germicidal lamps, and accessories. The conventional phototherapy equipment segment dominated the market with a valuation of USD 184.0 million in 2024; it is expected to reach a valuation of USD 250.5 million by 2035. The conventional phototherapy equipment comes with a fluorescent lamp for full-body or partial-body phototherapy.

Based on radiation, the global phototherapy market has been classified into UVA, UVB, and UVC. The UVB segment is expected to exhibit the highest CAGR of 5.26% during the forecast period. Narrowband UVB is frequently used because it is more effective for treating psoriasis than UVA or Broadband UVB.

Based on application, the global phototherapy market has been classified into skin disease treatment, neonatal jaundice management, and sterilization. The neonatal jaundice management segment is projected to exhibit the higher CAGR of 5.44% during the forecast period. Neonatal jaundice is referred to the yellowing of the skin and white part of the eyes of a new-born baby due to a high level of bilirubin. Factors such as the development of advanced infant phototherapy devices and the increasing initiatives undertaken by healthcare organizations to create awareness about neonatal jaundice are expected to drive the growth of the segment.

By end user, the global phototherapy market has been divided into hospital & clinic, dermatology center, and homecare. The hospital & clinic segment accounted for the largest market share in 2019. Large investments in healthcare infrastructure across various regions is expected to encourage the hospital & clinic segment growth during the forecast period.

Phototherapy Regional Report Analysis

The geographic analysis of the Global Phototherapy Market covers the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

By region, the study provides market insights into North America, Europe, Asia-Pacific and the Rest of the World. The North American Phototherapy Market accounted for USD 0.2 billion in 2022 and is expected to exhibit a significant CAGR growth during the study period. The United States has been dominating the market landscape and has played an important role in influencing the overall market. The major reason for the outstanding performance of this Region is the high demand for phototherapy solutions for skin treatments.

Further, the major countries studied in the market report are The U.S., Canada, Germany, France, the U.K., Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Europe's market of phototherapy accounts for the second-largest share owing to technological advancements and various financial aids, encouraging opting for this treatment. In 2020, the market was valued at approximately USD 56 Billion, while the French were valued at USD 34 Billion. One of the big opportunities for medical device manufacturers is the creation and expansion of 40 major hospitals across England by 2030, according to HospeTrack UK hospital intelligence. 

Competitive Analysis

The Key Players in the Global Phototherapy Market are Signify Holding (Netherlands), GE Healthcare (US), Natus Medical Incorporated (US), Herbert Waldmann GmbH & Co. KG (Germany), Phoenix Medical Systems (P) Ltd (India), Atom Medical Corporation (Japan), National Biological Corporation (US), Solarc Systems Inc. (Canada), The Daavlin Company (US), and Strata Skin Sciences, Inc. (US).

Key Developments

• North America remains the largest market for phototherapy, driven by high healthcare expenditure and advanced medical infrastructure.


• The Asia-Pacific region is emerging as the fastest-growing market, fueled by rising healthcare access and increasing prevalence of skin disorders.


• LED phototherapy equipment dominates the market, while fiberoptic phototherapy equipment is witnessing rapid growth due to its innovative applications.


• Key market drivers include the increasing incidence of skin disorders and the rising demand for home-based treatment options.